EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High Prevalence and Recent Increase in Multidrug-Resistant Helicobacter pylori in Bulgarian Patients: Pros and Cons of Culture-Based Susceptibility Testing

Lyudmila Boyanova, Liliya Yordanova Boyanova, Victor Kamburov, Vasil Svetoslavov Boyanov, Nikolay Katsarov, Nayden Kandilarov, Jose Medeiros, Zoya Spassova, Raina Gergova, Rumyana Markovska

Sci · 09.11.2026 · 8 (11) · 358

DOI: 10.3390/sci8110358 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sci, online erschienen am 09.11.2026. Verfasst von Lyudmila Boyanova und 9 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University—Sofia.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We investigated the anti-Helicobacter pylori activity of five antibiotics against isolates from 226 symptomatic adult patients during two periods (2024–2026 and 2022–2023). Antibiotic susceptibility testing (AST) was performed by MIC test strips and/or a validated disk diffusion method for tetracycline. Overall resistance was 58.8% for metronidazole, 57.1% for clarithromycin, 41.2% for levofloxacin, 9.3% for amoxicillin, and 3.5% for tetracycline. Resistance rates to 1, 2, and 3–5 antibiotics (the latter defined as multidrug resistance, MDR) were 28.8%, 33.6%, and 23.9%, respectively. In 2024–2026, metronidazole and clarithromycin resistance prevalence exceeded 62%, and four patients/isolates had quadruple/quintuple resistance. In the second period, MDR rates were twice as high as in the first period, reaching 27.1% and 29.9%, respectively. Culture-based AST can detect resistance due to various mechanisms in H. pylori and determine exact (low or high) resistance levels. Briefly, we found high resistance rates to metronidazole, clarithromycin, levofloxacin, and MDR during the last few years, possibly due to high national antibiotic consumption. Phenotypic AST is useful for choosing individualized/tailored eradication regimens in treated patients in countries/regions with high H. pylori resistance/MDR. In the era of growing antibiotic resistance, culture-based AST is important and, therefore, should not be neglected.

Förderung

  • Medical University—Sofia

Zitieren

APA

Boyanova, L., Boyanova, L. Y., Kamburov, V., Boyanov, V. S., Katsarov, N., Kandilarov, N., Medeiros, J., Spassova, Z., Gergova, R., & Markovska, R. (2026). High Prevalence and Recent Increase in Multidrug-Resistant Helicobacter pylori in Bulgarian Patients: Pros and Cons of Culture-Based Susceptibility Testing. Sci, 8(11), 358. https://doi.org/10.3390/sci8110358

Vancouver

Boyanova L, Boyanova LY, Kamburov V, Boyanov VS, Katsarov N, Kandilarov N, et al. High Prevalence and Recent Increase in Multidrug-Resistant Helicobacter pylori in Bulgarian Patients: Pros and Cons of Culture-Based Susceptibility Testing. Sci. 2026;8(11):358. doi:10.3390/sci8110358

BibTeX
@article{Boyanova2026,
  author = {Boyanova, Lyudmila and Boyanova, Liliya Yordanova and Kamburov, Victor and Boyanov, Vasil Svetoslavov and Katsarov, Nikolay and Kandilarov, Nayden and Medeiros, Jose and Spassova, Zoya and Gergova, Raina and Markovska, Rumyana},
  title = {High Prevalence and Recent Increase in Multidrug-Resistant Helicobacter pylori in Bulgarian Patients: Pros and Cons of Culture-Based Susceptibility Testing},
  journal = {Sci},
  year = {2026},
  volume = {8},
  number = {11},
  pages = {358},
  doi = {10.3390/sci8110358}
}
Kostenlos starten →